Insight by Abdul Wasay, Chief Operating Officer at The Business Research Company
In response to fluctuating tariffs and geopolitical trade developments, the Genomics In Cancer Care Market Outlook 2025 analyses how businesses are adapting through supply chain diversification and strategic sourcing.
What Are the Expected Market Growth Rates for the Genomics In Cancer Care Market?
The market size of the genomics in cancer care saw significant growth in recent years. The market which was valued at $17.6 billion in 2024 is projected to increase to $20.56 billion in 2025, with a compound annual growth rate (CAGR) of 16.8%.
What Are the Expected Market Growth Trends for the Genomics In Cancer Care Market Through 2029?
The Genomics In Cancer Care Global Market size is projected to reach $37.77 billion in 2029, with a compound annual growth rate (CAGR) of 16.4%.
Download the Free Sample Now:
What Are the Key Business Drivers in the Genomics In Cancer Care Market Landscape?
The key drivers in the genomics in cancer care market are:
• Increasing prevalence of cancer
• Advancements in data analytics
• Market expansion in emerging economies
• Improvements in healthcare infrastructure
How Is the Genomics In Cancer Care Market Divided Across Key Categories?
The genomics in cancer caremarket covered in this report is segmented –
1) By Product Type: Instruments, Consumables, Services
2) By Technology: PCR (?Polymerase Chain Reaction), MicroArrays, Genome Sequencing, Other Technologies
3) By Application: Diagnostics, Personalized Medicine, Drug Discovery And Development, Research
4) By End-User: Hospitals, Government Institutes, Research Facilities
Explore the Complete Market Report:
What Are the Ongoing Trends in the Genomics In Cancer Care Market?
The key trends in the genomics in cancer care market are:
• Technological advancements are expected to definitively shape the future of the genomics in cancer care market.
• The continued push towards personalized medicine is a substantial trend in the market.
• Reduced costs of genomic sequencing have been observed as an up-and-coming trend.
• Increasing regulatory support and guidelines, as well as growing patient awareness and demand, are also major trends to watch for.
Which Companies are Expanding in the Genomics In Cancer Care Industry?
Major players in the genomics in cancer care market are:
• Illumina Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• PerkinElmer Inc.
• QIAGEN N.V.
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Pacific Biosciences of California Inc.
• Roche Holding AG
• Quest Diagnostics Incorporated
• DiaSorin S.p.A.
• BGI Group
• Myriad Genetics Inc.
• NeoGenomics Laboratories
• Foundation Medicine Inc.
• Intermountain Healthcare
• Laboratory Corporation of America Holdings
• Flatiron Health Inc.
• Personal Genome Diagnostics Inc.
• Natera Inc.
• GRAIL Inc.
• Freenome Holdings Inc.
• Caris Life Sciences Inc.
• Tempus Labs Inc.
• OncoDNA S.A.
• Biocept Inc.
• GenomOncology Corp.
• OncoCyte Corporation
• PathAI Inc.
• Enzyme Corporation
• Karius Inc.
• N-of-One Inc.
• Oncora Medical Inc.
• Paradigm Diagnostics Inc.
• PierianDx Inc.
• Predicine Inc.
• Resolution Bioscience Inc.
• Strata Oncology Inc.
Which is the Largest Region the Global Genomics In Cancer Care Market?
North America was the largest region in the genomics in cancer care market in 2024
